TREA

97867321 - OPENPICHIA

Follow

Information

  • Trademark
  • 97867321
  • Serial Number
    97867321
  • Registration Number
    7773262
  • Filing Date
    March 31, 2023
    2 years ago
  • Registration Date
    April 29, 2025
    9 months ago
  • Transaction Date
    April 30, 2025
    9 months ago
  • Status Date
    April 29, 2025
    9 months ago
  • Published for Opposition Date
    March 11, 2025
    11 months ago
  • Location Date
    April 28, 2025
    9 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    CORWIN, KEVIN
  • Attorney Docket Number
    HDCPA-T485US
    Attorney Name
    Clifford D. Hyra
  • Owners
Information
Mark Drawing Code
4
Mark Identification
OPENPICHIA
Case File Statements
  • GS0051: Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substances, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals, and preparations in the nature of medicated wheat-free and gluten-free pasta, crackers for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Medical preparations and substances, namely, fungal preparations in the nature of fungal medications for medical purposes, probiotic preparations for medical use, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations and substances, namely, fungal preparations in the nature of fungal medications for veterinary purposes; Veterinary preparations in the nature of veterinary pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Biologicals preparations for medical and veterinary use, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Diagnostic and therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, diagnostic preparations for veterinary and medical use, pharmaceutical preparations and biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Cultures for pharmaceutical, medical and veterinary purposes, namely, diagnostic media for fungal cultures and cultures of microorganisms, all for medical or veterinary purposes; Preparations and substances for use in drug discovery, namely, sterilizing preparations, growth media preparations in the nature of cell growth media for growing cells for medical and veterinary purposes, and reagents and media for medical and veterinary diagnostic purposes, namely, such media and reagents serving as inoculate, clinical medical reagents, and diagnostic reagents
  • PM0001: OPEN PICHIA
  • GS0421: Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, biotechnology, the food and animal feed industries, veterinary science, manufacturing of biological preparations, and in the field of industrial biotechnology; Natural science services, namely, scientific research and medical research in the fields of bacteriological, fungal, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services
Case File Event Statements
  • 4/4/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/25/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/12/2023 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/14/2023 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/14/2023 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/14/2023 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/5/2023 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/5/2023 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/5/2023 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/31/2024 - a year ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 5/31/2024 - a year ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/30/2024 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/30/2024 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/30/2024 - a year ago
    17 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 8/30/2024 - a year ago
    16 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 5/31/2024 - a year ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 8/30/2024 - a year ago
    13 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 12/13/2024 - a year ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/19/2024 - a year ago
    19 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 3/5/2025 - 11 months ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/11/2025 - 11 months ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/11/2025 - 11 months ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/29/2025 - 9 months ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/29/2025 - 9 months ago
    24 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC